{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:10:12Z","timestamp":1788610212296,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100014118","name":"Savient Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014118","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Crealta Pharmaceuticals"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1UL1TR001445"],"award-info":[{"award-number":["1UL1TR001445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10067-017-3729-z","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T07:49:15Z","timestamp":1497599355000},"page":"2101-2107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking"],"prefix":"10.1007","volume":"36","author":[{"given":"Dodji V.","family":"Modjinou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Krasnokutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soterios","family":"Gyftopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Karis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria B.","family":"Crittenden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Pillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,16]]},"reference":[{"key":"3729_CR1","unstructured":"Zhu Y, Pandya BJ, Choi HK (2011 Jul 28) Prevalence of gout and hyperuricemia in the US general population. Arthritis Rheum"},{"key":"3729_CR2","doi-asserted-by":"crossref","unstructured":"Zhu Y, Pandya BJ, Choi HK (2012 Jul) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med 125(7):679\u2013687 e671","DOI":"10.1016\/j.amjmed.2011.09.033"},{"issue":"2","key":"3729_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","volume":"124","author":"RT Keenan","year":"2011","unstructured":"Keenan RT, O'Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS et al (2011 Feb) Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med 124(2):155\u2013163","journal-title":"Am J Med"},{"issue":"5","key":"3729_CR4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3899\/jrheum.071229","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J et al (2009 May) Quality of life and disability in patients with treatment-failure gout. J Rheumatol 36(5):1041\u20131048","journal-title":"J Rheumatol"},{"issue":"1","key":"3729_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","volume":"73","author":"F Perez-Ruiz","year":"2014","unstructured":"Perez-Ruiz F, Martinez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E (2014 Jan) Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 73(1):177\u2013182","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3729_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/00325481.2016.1113840","volume":"128","author":"P Khanna","year":"2016","unstructured":"Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R (2016 Jan) A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift. Postgrad Med 128(1):34\u201340","journal-title":"Postgrad Med"},{"issue":"12","key":"3729_CR7","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1002\/art.30649","volume":"63","author":"F Perez-Ruiz","year":"2011","unstructured":"Perez-Ruiz F, Herrero-Beites AM, Carmona L (2011 Dec) A two-stage approach to the treatment of hyperuricemia in gout: the \u201cdirty dish\u201d hypothesis. Arthritis Rheum 63(12):4002\u20134006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3729_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/ar3489","volume":"13","author":"FM McQueen","year":"2011","unstructured":"McQueen FM, Doyle A, Dalbeth N (2011) Imaging in gout\u2014what can we learn from MRI, CT, DECT and US? Arthritis Res Ther 13(6):246","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3729_CR9","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/ar4318","volume":"15","author":"HS Baraf","year":"2013","unstructured":"Baraf HS, Becker MA, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, Rehrig CD et al (2013) Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy. Arthritis Res Ther. 15(5):R137","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"3729_CR10","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.110272","volume":"38","author":"N Dalbeth","year":"2011","unstructured":"Dalbeth N, McQueen FM, Singh JA, MacDonald PA, Edwards NL, Schumacher HR Jr et al (2011 Jul) Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol 38(7):1458\u20131461","journal-title":"J Rheumatol"},{"issue":"11","key":"3729_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/1756-185X.12921","volume":"19","author":"YS Suh","year":"2016","unstructured":"Suh YS, Cheon YH, Kim JE, Kim JM, Kim SH, Lee WS et al (2016 Nov) Usefulness of plain radiography for assessing hypouricemic treatment response in patients with tophaceous gout. Int J Rheum Dis 19(11):1183\u20131188","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"3729_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.berh.2016.10.010","volume":"30","author":"EG Araujo","year":"2016","unstructured":"Araujo EG, Manger B, Perez-Ruiz F, Thiele RG (2016 Aug) Imaging of gout: new tools and biomarkers? Best Pract Res Clin Rheumatol 30(4):638\u2013652","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"3729_CR13","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/acr.20527","volume":"63","author":"RG Howard","year":"2011","unstructured":"Howard RG, Pillinger MH, Gyftopoulos S, Thiele RG, Swearingen CJ, Samuels J (2011 Oct) Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers. Arthritis care & research 63(10):1456\u20131462","journal-title":"Arthritis care & research"},{"issue":"9","key":"3729_CR14","first-page":"1888","volume":"34","author":"F Perez-Ruiz","year":"2007","unstructured":"Perez-Ruiz F, Martin I, Canteli B (2007 Sep) Ultrasonographic measurement of tophi as an outcome measure for chronic gout. J Rheumatol 34(9):1888\u20131893","journal-title":"J Rheumatol"},{"issue":"10","key":"3729_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1136\/ard.2008.099713","volume":"68","author":"HK Choi","year":"2009","unstructured":"Choi HK, Al-Arfaj AM, Eftekhari A, Munk PL, Shojania K, Reid G et al (2009 Oct) Dual energy computed tomography in tophaceous gout. Ann Rheum Dis 68(10):1609\u20131612","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3729_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1055\/s-0028-1109820","volume":"182","author":"A Artmann","year":"2010","unstructured":"Artmann A, Ratzenbock M, Noszian I, Trieb K (2010 Mar) Dual energy CT\u2014a new perspective in the diagnosis of gout. Rofo 182(3):261\u2013266","journal-title":"Rofo"},{"issue":"6","key":"3729_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3899\/jrheum.080814","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, MacDonald PA, Lloyd E, Lademacher C (2009 Jun) Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J Rheumatol 36(6):1273\u20131282","journal-title":"J Rheumatol"},{"key":"3729_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-med-080911-105830","volume":"64","author":"DB Crittenden","year":"2013","unstructured":"Crittenden DB, Pillinger MH (2013) New therapies for gout. Annu Rev Med 64:325\u2013337","journal-title":"Annu Rev Med"},{"issue":"7","key":"3729_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/jama.2011.1169","volume":"306","author":"JS Sundy","year":"2011","unstructured":"Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL et al (2011 Aug 17) Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306(7):711\u2013720","journal-title":"JAMA"},{"issue":"1","key":"3729_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000075","volume":"1","author":"EG Araujo","year":"2015","unstructured":"Araujo EG, Bayat S, Petsch C, Englbrecht M, Faustini F, Kleyer A et al (2015) Tophus resolution with pegloticase: a prospective dual-energy CT study. RMD Open 1(1):e000075","journal-title":"RMD Open"},{"issue":"4","key":"3729_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/art.10511","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A (2002 Aug) Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 47(4):356\u2013360","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3729_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/ard.2010.139899","volume":"70","author":"N Dalbeth","year":"2011","unstructured":"Dalbeth N, Schauer C, Macdonald P, Perez-Ruiz F, Schumacher HR, Hamburger S et al (2011 Apr) Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis 70(4):597\u2013604","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3729_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/rheumatology\/kem058","volume":"46","author":"RG Thiele","year":"2007","unstructured":"Thiele RG, Schlesinger N (2007 Jul) Diagnosis of gout by ultrasound. Rheumatology (Oxford) 46(7):1116\u20131121","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"3729_CR24","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1136\/annrheumdis-2011-200976","volume":"71","author":"HK Choi","year":"2012","unstructured":"Choi HK, Burns LC, Shojania K, Koenig N, Reid G, Abufayyah M et al (2012 Sep) Dual energy CT in gout: a prospective validation study. Ann Rheum Dis 71(9):1466\u20131471","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3729_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11926-014-0492-x","volume":"17","author":"A Chhana","year":"2015","unstructured":"Chhana A, Dalbeth N (2015 Mar) The gouty tophus: a review. Curr Rheumatol Rep 17(3):19","journal-title":"Curr Rheumatol Rep"},{"key":"3729_CR26","doi-asserted-by":"crossref","unstructured":"Martillo MA, Nazzal L, Crittenden DB (2014) The crystalization of monosodium urate. Current Rheumatology Reports In press","DOI":"10.1007\/s11926-013-0400-9"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3729-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3729-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3729-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:48:36Z","timestamp":1589442516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3729-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,16]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3729"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3729-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,16]]},"assertion":[{"value":"18 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Pillinger is currently or has recently been a consultant for Crealta, Horizon, AstraZeneca, SOBI and Ironwood, serves as a study site investigator for Takeda. Dr. Krasnokutsky is currently or has recently been a consultant for Crealta, Horizon, AstraZeneca and Ironwood. Dr. Keenan is a consultant for Horizon, Ironwood and AstraZeneca. Dr. Crittenden is currently employed by Amgen. Dr. Karis has served on a speakers bureau for Takeda. No other author has any disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest statement"}}]}}